SecBot SecBot
Insider Cluster (7 insiders) ·Filed Aug 25, 2026

ARDX

ARDELYX, INC.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 7 insiders, $0.2M total
Actionable Insight • Neutral

The cluster is too small relative to market cap to signal material bearish news. Monitor for any upcoming earnings or pipeline catalysts (ARDX is a biotech with no revenue from the filing) that could drive price action independent of insider activity. The uniform pricing suggests a pre-arranged plan — treat as non-informative.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled: T+20d ⚠ clustered
ARDX ▼ -9.92% at T+20d
NEUTRAL call -9.92% · α vs SPY -10.15% · entry $3.83 → $3.45
Next anchor: T+60d in 21d
Latest observation: T+43 +17.36% FF3 residual α
Entry = T+0 close
Aug 25, 2026
via day close
T+1d
-0.26%
call -0.26% · α -0.92%
$3.82
settled 2mo ago
T+5d
-0.78%
call -0.78% · α -0.66%
$3.80
settled 8w ago
T+20d
-9.92%
call -9.92% · α -10.15%
$3.45
settled 5w ago
T+60d
Pending
in 21d

Price Chart

Loading chart...

Executive Summary

Seven ARDX insiders, including the CEO and CFO, sold a total of $229K in open-market sales on August 21, 2026, all at $3.86 per share. The cluster is 100% selling with no buys, and the CEO alone sold $74K. At $932M market cap, the $229K total is only ~0.02% of market cap, which is trivial and routine, not indicative of material bearish information.

Key Financial Metrics

Direction
selling
Total Value
$229.0K
Insiders
7

Key Facts

  • 7 insiders sold a total of $229K in open-market sales on 2026-08-21
  • CEO Michael Raab sold $74K (19,178 shares) at $3.86
  • CFO Susan Hohenleitner sold $6K (1,558 shares) at $3.86
  • Total sales represent ~0.02% of $932M market cap
  • All 20 trades occurred on the same day at the same price, suggesting a coordinated liquidity event (e.g., tax withholding or 10b5-1 plan) rather than opportunistic selling
  • No insider purchases were reported in the cluster

Financial Impact

Total insider sales of $229K, or ~0.02% of market cap — immaterial

insider ownership

Risk Factors

  • Insider selling could accelerate if the stock declines further, but current levels are trivial
  • No cross-filing context (earnings, press releases, or agreements) was provided to amplify the signal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARDX-1787728031885
16 reports for ARDX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ARDX, sortable and filterable
TypeNow
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 2/10
$3.39awaiting T+20awaiting T+20$3.00 (−11.50%)
Aug 25, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.83 $3.45▼ −9.92%▼ −10.15%$3.00 (−21.67%)
Aug 25, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.83 $3.45▼ −9.92%▼ −10.15%$3.00 (−21.67%)
Aug 21, 2026
9w ago
144
NEUTRAL ★ 2/10
$3.74 $3.62▼ −3.21%▼ −4.52%$3.00 (−19.79%)
Aug 21, 2026
9w ago
144
NEUTRAL ★ 2/10
$3.74 $3.62▼ −3.21%▼ −4.52%$3.00 (−19.79%)
Aug 17, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$3.92 $3.40▼ −13.27%▼ −12.28%$3.00 (−23.47%)
Aug 15, 2026
10w ago
Institutional Cluster
BULLISH ★ 4/10
$4.06 $3.52▼ −13.30%▼ −11.77%$3.00 (−26.11%)
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 4/10
$5.27 $5.04▼ −4.36%▼ −3.95%$3.00 (−43.07%)
Jun 17, 2026
18w ago
8-K
NEUTRAL ★ 3/10
$6.05 $5.13▼ −15.29%▼ −15.82%$3.00 (−50.41%)
Jun 15, 2026
19w ago
144
NEUTRAL ★ 3/10
$5.67 $5.16▼ −8.99%▼ −9.19%$3.00 (−47.09%)
Showing 10 of 16

US Market Status

Market Closed · Opens in 5h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 26, 2026